These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8764370)

  • 21. Differential effects of regulator of G protein signaling (RGS) proteins on serotonin 5-HT1A, 5-HT2A, and dopamine D2 receptor-mediated signaling and adenylyl cyclase activity.
    Ghavami A; Hunt RA; Olsen MA; Zhang J; Smith DL; Kalgaonkar S; Rahman Z; Young KH
    Cell Signal; 2004 Jun; 16(6):711-21. PubMed ID: 15093612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterologous sensitization of recombinant adenylate cyclases by activation of D(2) dopamine receptors.
    Cumbay MG; Watts VJ
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1201-9. PubMed ID: 11356947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Membrane receptors and coupling proteins in adenohypophyseal cells].
    Cussac D; Caccavelli L; Pellegrini I; Audinot V; Jaquet P; Enjalbert A
    C R Seances Soc Biol Fil; 1993; 187(1):14-23. PubMed ID: 8242419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective activation of Galphao by D2L dopamine receptors in NS20Y neuroblastoma cells.
    Watts VJ; Wiens BL; Cumbay MG; Vu MN; Neve RL; Neve KA
    J Neurosci; 1998 Nov; 18(21):8692-9. PubMed ID: 9786976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SH3 binding domains in the dopamine D4 receptor.
    Oldenhof J; Vickery R; Anafi M; Oak J; Ray A; Schoots O; Pawson T; von Zastrow M; Van Tol HH
    Biochemistry; 1998 Nov; 37(45):15726-36. PubMed ID: 9843378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fish somatostatin sst3 receptor: comparison of radioligand and GTPgammaS binding, adenylate cyclase and phospholipase C activities reveals different agonist-dependent pharmacological signatures.
    Siehler S; Nunn C; Zupanc GK; Hoyer D
    Auton Autacoid Pharmacol; 2005 Jan; 25(1):1-16. PubMed ID: 15659149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel regulatory properties of human type 9 adenylate cyclase.
    Cumbay MG; Watts VJ
    J Pharmacol Exp Ther; 2004 Jul; 310(1):108-15. PubMed ID: 14996950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutant alpha subunits of Gi2 inhibit cyclic AMP accumulation.
    Wong YH; Federman A; Pace AM; Zachary I; Evans T; Pouysségur J; Bourne HR
    Nature; 1991 May; 351(6321):63-5. PubMed ID: 1851251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opioid mu, delta, and kappa receptor-induced activation of phospholipase C-beta 3 and inhibition of adenylyl cyclase is mediated by Gi2 and G(o) in smooth muscle.
    Murthy KS; Makhlouf GM
    Mol Pharmacol; 1996 Oct; 50(4):870-7. PubMed ID: 8863832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual signaling of human Mel1a melatonin receptors via G(i2), G(i3), and G(q/11) proteins.
    Brydon L; Roka F; Petit L; de Coppet P; Tissot M; Barrett P; Morgan PJ; Nanoff C; Strosberg AD; Jockers R
    Mol Endocrinol; 1999 Dec; 13(12):2025-38. PubMed ID: 10598579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of a novel PKC isoform synergistically enhances D2L dopamine receptor-mediated sensitization of adenylate cyclase type 6.
    Beazely MA; Watts VJ
    Cell Signal; 2005 May; 17(5):647-53. PubMed ID: 15683739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of type II adenylate cyclase by D2 and D4 but not D3 dopamine receptors.
    Watts VJ; Neve KA
    Mol Pharmacol; 1997 Aug; 52(2):181-6. PubMed ID: 9271339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coupling of 5-HT1A autoreceptors to inhibition of mitogen-activated protein kinase activation via G beta gamma subunit signaling.
    Kushwaha N; Albert PR
    Eur J Neurosci; 2005 Feb; 21(3):721-32. PubMed ID: 15733090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. D2 dopamine receptors modulate Galpha-subunit coupling of the CB1 cannabinoid receptor.
    Jarrahian A; Watts VJ; Barker EL
    J Pharmacol Exp Ther; 2004 Mar; 308(3):880-6. PubMed ID: 14634050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dexras1 blocks receptor-mediated heterologous sensitization of adenylyl cyclase 1.
    Nguyen CH; Watts VJ
    Biochem Biophys Res Commun; 2005 Jul; 332(3):913-20. PubMed ID: 15913563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of polyclonal anti-D2 dopamine receptor antibodies using sequence-specific peptides.
    Boundy VA; Luedtke RR; Artymyshyn RP; Filtz TM; Molinoff PB
    Mol Pharmacol; 1993 May; 43(5):666-76. PubMed ID: 8502224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antisense oligodeoxynucleotide to the Gi2 protein alpha subunit sequence inhibits an opioid-induced increase in the intracellular free calcium concentration in ND8-47 neuroblastoma x dorsal root ganglion hybrid cells.
    Tang T; Kiang JG; Côté TE; Cox BM
    Mol Pharmacol; 1995 Aug; 48(2):189-93. PubMed ID: 7651350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The rat D4 dopamine receptor couples to cone transducin (Galphat2) to inhibit forskolin-stimulated cAMP accumulation.
    Yamaguchi I; Harmon SK; Todd RD; O'Malley KL
    J Biol Chem; 1997 Jun; 272(26):16599-602. PubMed ID: 9195972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. G protein specificity in receptor-effector coupling. Analysis of the roles of G0 and Gi2 in GH4C1 pituitary cells.
    Liu YF; Jakobs KH; Rasenick MM; Albert PR
    J Biol Chem; 1994 May; 269(19):13880-6. PubMed ID: 8188665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A region of the third intracellular loop of the short form of the D2 dopamine receptor dictates Gi coupling specificity.
    Senogles SE; Heimert TL; Odife ER; Quasney MW
    J Biol Chem; 2004 Jan; 279(3):1601-6. PubMed ID: 14581469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.